Related Experiment Videos
Phenotypic analysis in diffuse, large cell lymphoma. Clinical and histologic associations
American Journal of Clinical Pathology
|April 1, 1986
Summary
This study found no significant link between immunologic phenotype and diffuse, large cell lymphoma (DLCL) outcomes. However, bone marrow involvement was associated with specific DLCL subtypes, suggesting potential diagnostic value.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Diffuse, large cell lymphoma (DLCL) is a heterogeneous non-Hodgkin lymphoma.
- Understanding the relationships between immunologic phenotype, histology, and clinical presentation is crucial for DLCL management.
Purpose of the Study:
- To investigate associations between immunologic phenotype, histologic subtype, and clinical features in DLCL.
- To determine the clinical implications of immunophenotypic analysis in DLCL patients.
Main Methods:
- Established a computerized registry for prospective collection of immunologic, histologic, and clinical data.
- Utilized immunofluorescence and immunoperoxidase techniques on various tissue specimens for immunophenotypic analysis.
- Assigned B-cell lineage using monoclonal antibody reagents in paraffin-embedded sections.
Main Results:
- A definitive immunologic phenotype was established in most DLCL cases.
- No statistically significant association was found between immunologic phenotype and clinical parameters like therapy response or survival.
- Bone marrow involvement showed a significant association with vague nodularity and cleaved cell subtypes.
Conclusions:
- Immunophenotypic analysis can assign lineage and differentiation stage in most DLCL specimens.
- The study did not demonstrate significant clinical implications of immunophenotypic analysis for DLCL patients in this series.
- Further research is needed to clarify the clinical utility of immunophenotyping in DLCL.